http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2120294-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fb2e5a911613d079c5fccfa1eddc7a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8aa0527280b26e73b8e0fbae895dabea
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 1996-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc87a4dadff82ca213479e25886dbc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab7f8f2ede060f240e2dfcd0771f2f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56dc6119a1b694161995847457c55663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47647876bbbc3e18fb45639e096df0c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf87b7fb487575bc53b5bc082a8f3f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72206e26d92b736c9c16d204789cc9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3e164a5d608d7509fea0f6f3839b04
publicationDate 1998-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2120294-C1
titleOfInvention Drug
abstract FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: invention proposes 0.2% chelepine D solution in 6% polyglucine in combination with chelepine D tablets. Drug shows antiviral and antiinflammatory total and local effect both at surface and deep keratitis forms combined with stroma damage. Drug can be used for treatment of patients with herpes-viral and adenoviral eye diseases. EFFECT: enhanced effectiveness of drug proposed. 1 cl, 6 ex
priorityDate 1996-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415711165
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415858804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426387251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415861868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415858154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488842
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169137

Total number of triples: 40.